NCT07335991

Brief Summary

This study aims to investigate whether vitamin A supplementation can influence spinal curve magnitude in idiopathic scoliosis children and potentially prevent its de novo development.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started May 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
May 2025Jun 2028

Study Start

First participant enrolled

May 13, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 13, 2026

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

May 15, 2026

Status Verified

May 1, 2026

Enrollment Period

3.1 years

First QC Date

January 1, 2026

Last Update Submit

May 14, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Scoliosis Curve Angle

    A long standard standing whole spine radiograph will be used for measuring curve size in terms of Cobb angle according to the standard Cobb method

    Routine follow-up visits will be scheduled 6 months apart up to 24 months

  • Angle of Trunk Rotation

    In addition to spinal X-rays, a Scoliometer can also help monitor curve progression. The Scoliometer is an inclinometer that measures the asymmetries between the sides of the trunk by measuring axial rotation in degrees. Numerous studies have found a high correlation between trunk axial rotation (ATR) values and the Cobb angles.

    Routine follow-up visits will be scheduled 6 months apart up to 24 months

Secondary Outcomes (5)

  • Scoliosis Research Society-22 (SRS-22) questionnaire

    Routine follow-up visits will be scheduled 6 months apart up to 24 months

  • Change in Serum Vitamin A (Retinol) Level

    At baseline and months 6

  • Serum Levels of Vitamin D

    At baseline and months 6

  • Change in Gene Expression Levels of biomarkers

    At baseline and months 6

  • Circadian rhythm Measurements

    Routine follow-up visits will be scheduled 6 months apart up to 24 months

Study Arms (2)

Vitamin A Supplementation plus Nutritional Education

EXPERIMENTAL

1. Dietary Supplement: A daily oral dose of 2000 IU Vitamin A (as retinyl palmitate or acetate) for 6 consecutive months. 2. Behavioral: Nutritional Education: A one-time, standardized educational session at baseline delivered by a study dietitian. The session covers principles of a balanced diet for bone health, with a focus on food sources rich in vitamin A.

Dietary Supplement: Vitamin A

Nutritional Education Only

ACTIVE COMPARATOR

1. Behavioral: Nutritional Education: An identical one-time, standardized educational session and materials as provided to Arm 1. 2. No study-provided vitamin A supplements will be administered.

Behavioral: Nutritional Education

Interventions

Vitamin ADIETARY_SUPPLEMENT

Vitamin A supplements plus Nutritional Education

Vitamin A Supplementation plus Nutritional Education

Nutritional Education Only

Nutritional Education Only

Eligibility Criteria

Age6 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 6 and 15 years.
  • Biochemically confirmed vitamin A deficiency (serum retinol \< 0.20 mg/L) or insufficiency (serum retinol 0.20-0.29 mg/L).
  • Has undergone radiographic evaluation (standing full-spine X-ray) for idiopathic scoliosis at the initial clinic visit.
  • Skeletally immature (Risser sign 0-3) with a major Cobb angle \< 40 degrees at baseline.
  • Written informed consent/assent provided by the participant and legal guardian.

You may not qualify if:

  • Unwillingness or inability to comply with all study procedures and follow-up visits.
  • Plans to relocate outside the study area within the next 24 months.
  • Previous high-dose vitamin A supplementation therapy within the past 12 months.
  • Clinical signs of severe vitamin A deficiency syndrome (e.g., xerophthalmia, Bitot's spots).
  • Serum vitamin A level \> 0.70 mg/L (to avoid risk of hypervitaminosis A).
  • Severe chronic health conditions that could confound study outcomes, including but not limited to:
  • Known syndromic, neuromuscular, or congenital musculoskeletal causes of scoliosis.
  • History of spine surgery or significant spinal trauma.
  • Spinal tumor.
  • Leg length discrepancy \> 20 mm.
  • Other severe chronic diseases (e.g., poorly controlled diabetes, chronic liver or renal disease, malabsorption syndromes).
  • Severe obesity (body mass index z-score ≥ 3).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, 325000, China

RECRUITING

MeSH Terms

Conditions

Vitamin A Deficiency

Interventions

Vitamin A

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

RetinoidsCarotenoidsPolyenesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCyclohexenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicTerpenesDiterpenesPigments, BiologicalBiological Factors

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The radiologists measuring Cobb angles will be blinded to treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Chief physician, Doctorial superviso

Study Record Dates

First Submitted

January 1, 2026

First Posted

January 13, 2026

Study Start

May 13, 2025

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

May 15, 2026

Record last verified: 2026-05

Locations